Dataset Information


Biodegradable Hollow Mesoporous Silica Nanoparticles for Regulating Tumor Microenvironment and Enhancing Antitumor Efficiency.

ABSTRACT: There is accumulating evidence that regulating tumor microenvironment plays a vital role in improving antitumor efficiency. Herein, to remodel tumor immune microenvironment and elicit synergistic antitumor effects, lipid-coated biodegradable hollow mesoporous silica nanoparticle (dHMLB) was constructed with co-encapsulation of all-trans retinoic acid (ATRA), doxorubicin (DOX) and interleukin-2 (IL-2) for chemo-immunotherapy. The nanoparticle-mediated combinational therapy provided a benign regulation on tumor microenvironment through activation of tumor infiltrating T lymphocytes and natural killer cells, promotion of cytokines secretion of IFN-? and IL-12, and down-regulation of immunosuppressive myeloid-derived suppressor cells, cytokine IL-10 and TGF-?. ATRA/DOX/IL-2 co-loaded dHMLB demonstrated significant tumor growth and metastasis inhibition, and also exhibited favorable biodegradability and safety. This nanoplatform has great potential in developing a feasible strategy to remodel tumor immune microenvironment and achieve enhanced antitumor effect.


PROVIDER: S-EPMC5595131 | BioStudies | 2017-01-01T00:00:00Z

REPOSITORIES: biostudies

Similar Datasets

1000-01-01 | S-EPMC6276300 | BioStudies
1000-01-01 | S-EPMC5566104 | BioStudies
2019-01-01 | S-EPMC6735371 | BioStudies
2020-01-01 | S-EPMC7147369 | BioStudies
2016-01-01 | S-EPMC4957695 | BioStudies
2019-01-01 | S-EPMC6437598 | BioStudies
1000-01-01 | S-EPMC5440031 | BioStudies
2021-01-01 | S-EPMC7914337 | BioStudies
2018-01-01 | S-EPMC6475912 | BioStudies
2019-01-01 | S-EPMC6735506 | BioStudies